Subsequently, our results suggest that PRRT3-AS1 may be required for cancer cell migration in SKCM through cellular experiments for the first time, suggesting that PRRT3-AS1 is not only a potential biomarker but also a potential therapeutic target of SKCM. Here, PRRT3 is linked to cancer.